Novel Jatrophane Diterpenoids from Euphorbia esul a Promotes Lipid Clearance by Transcriptional Regulation of PCSK9
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c00779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Tong Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, People's Republic of China. Hauptthemen laut MEDLINE: Euphorbia, Diterpenes, Proprotein Convertase 9. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: State Key Laboratory of Drug Research, Chinese Academy of Sciences, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
PCSK9 has been recognized as an efficient target for hyperlipidemia and related cardiovascular/cerebrovascular diseases. However, PCSK9 inhibitors in the clinic are all biological products, and no small molecules are available yet. In the current work, we discovered that the crude extract of Euphorbia esula (E. esula) promoted LDL uptake in vitro and then obtained 8 new and 12 known jatrophane diterpenoids by activity-guided isolation. After summarized their structure-activity relationship of PCSK9 inhibition, we selected compound 11 (C11) with potent activity and high abundance to investigate its mechanism and in vivo efficacy. Mechanistically, C11 bound with HNF1α to influence its nuclear distribution and subsequently inhibit PCSK9 transcription, thereby enhancing LDLR and promoting LDL uptake. Moreover, C11 demonstrated obvious lipid-lowering activity in HFD mouse model. In conclusion, we first revealed the novel application of E. esula in the discovery of a lipid-lowering candidate and highlighted the potential of C11 in the treatment of hyperlipidemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, People's Republic of China.
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, People's Republic of China.
- University of Chinese Academy of Sciences, No. 19A Yuquan Road, Beijing 100049, People's Republic of China.
- School of Pharmacy, Fudan University, Shanghai 201203, PR China.
ORCID-Profile: Lijiang Xuan
Förderung
- State Key Laboratory of Drug Research, Chinese Academy of Sciences
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Chen, T., Hou, A., Guo, P., Peng, S., Qin, G., Ding, A., Hu, X., Duan, Y., Chen, J., Gong, L., & Xuan, L. (2024). Novel Jatrophane Diterpenoids from Euphorbia esul a Promotes Lipid Clearance by Transcriptional Regulation of PCSK9. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00779
Vancouver
Chen T, Hou A, Guo P, Peng S, Qin G, Ding A, et al. Novel Jatrophane Diterpenoids from Euphorbia esul a Promotes Lipid Clearance by Transcriptional Regulation of PCSK9. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00779
BibTeX
@article{Chen2024,
author = {Chen, Tong and Hou, Aijun and Guo, Pengju and Peng, Shou and Qin, Guoqing and Ding, Aoxue and Hu, Xianggang and Duan, Yelin and Chen, Jing and Gong, Likun and Xuan, Lijiang},
title = {Novel Jatrophane Diterpenoids from Euphorbia esul a Promotes Lipid Clearance by Transcriptional Regulation of PCSK9},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c00779}
}
EUVIMED